Agoracom: Small Cap Investment - Zenith Epigenetics

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

TNBC no longer active?

jonzobot

Jun 27, 2023 05:05PM

Re: TNBC no longer active?

tada

Jun 28, 2023 12:10AM

jonzobot

Rank: President [?]

Points: 2527 [?]

Votes: 20 Score: 3.6 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: TNBC no longer active?

in response to

Re: TNBC no longer active?

tada

posted on Jun 28, 2023 12:37PM

I'm not sure that's true for the two phase 2's. Zenith is still listed as the sponsor on both so has control.

In order to run these trials, Zenith sold a licence to Newsoara for ZEN-3694 in Asia. Part of the deal was that Newsoara would fund development costs.

News article here.

3 Recommendations

Re: TNBC no longer active?

tada

Jun 28, 2023 04:32PM

Re: TNBC no longer active?

jonzobot

Jun 29, 2023 11:24AM